USUARIOS REGISTRADOS
Ingrese con su correo institucional
Ingrese con su correo institucional
Unidad de Investigación
ID: 741
INSTITUTO CLODOMIRO PICADO
Mostrando 18 personas investigadoras
| NOMBRE |
|
CORREO ELECTRÓNICO |
|---|---|---|
| Acuña Espinola, Gabriel Angel | Inactivo | |
| Aguilar Ulloa, Wendy Maria | Inactivo | wendy.aguilarulloa@ucr.ac.cr |
| Alape Giron, Alberto | Activo | alberto.alape@ucr.ac.cr |
| Alfaro Chinchilla, Adriana | Activo | adriana.alfaro15@ucr.ac.cr |
| Altamirano Monge, Jose | Inactivo | |
| Araya Pizarro, Xavier Alberto | Activo | |
| Arce Estrada, Denice | Inactivo | |
| Arguedas Gómez, Mauricio José | Activo | mauricio.arguedasgomez@ucr.ac.cr |
| Arias Rodríguez, Jazmín Melania | Inactivo | jazmin.arias@ucr.ac.cr |
| Arias Gomez, Berny | Inactivo | |
| Badilla Vargas, Lisa Stephanie | Inactivo | |
| Bonilla Murillo, Fabián | Activo | fabian.bonilla@ucr.ac.cr |
| Boroschek Kraoskopf, Ruben | Inactivo | |
| Calvete Chornet, Juan José | Inactivo | jcalvete@ibv.csic.es |
| Calvo Corea, Silvia | Inactivo | |
| Camacho Umaña, Ericka | Activo | erika.camachoumana@ucr.ac.cr |
| Camacho Umaña, Erika Maria | Inactivo | |
| Castro Castro, Ana Cristina | Inactivo |
Mostrando 95 personal colaborador
Mostrando 20 proyectos
Mostrando 22 proyectos en colaboración
Mostrando 674 publicaciones
| TÍTULO | TIPO | AUTOR | PROYECTOS | FECHA |
|---|---|---|---|---|
| Toxinological profile and histopathological alterations induced by Bothrocophias campbelli venom from Colombia |
|
|
No disponible |
2024 |
| Venomics of Leiurus abdullahbayrami, the most lethal scorpion in the Levant region of the Middle East |
|
|
No disponible |
2024 |
| Assessing target specificity of the small molecule inhibitor MARIMASTAT to snake venom toxins: a novel application of thermal proteome profiling |
|
|
No disponible |
2024 |
| Venomics of scorpion Ananteris platnicki (Lourenço, 1993), a New World buthid that inhabits Costa Rica and Panama |
|
|
No disponible |
2024 |
| Proteomic analysis and lethality of the venom of Aegaeobuthus nigrocinctus, a scorpion of potential medical significance in the Middle East |
|
|
No disponible |
2024 |
| Exploring venom diversity in Mixcoatlus browni and Mixcoatlus barbouri: A comparative analysis of two rare Mexican snake species with crotoxin-like presence. |
|
|
No disponible |
2024 |
| Mandibular gland proteomics of the Mexican alligator lizard, Abronia graminea, and the red-lipped arboreal alligator lizard, Abronia lythrochila |
|
|
No disponible |
2024 |
| Venom of the neotropical rattlesnake, Crotalus culminatus: Intraspecific variation, neutralization by antivenoms, and immunogenicity in rabbits |
|
|
No disponible |
2024 |
| Comparative in vitro and in silico analysis of the ability of basic Asp49 phospholipase A2 and Lys49-phospholipase A2-like myotoxins from Bothrops diporus venom to inhibit the metastatic potential of murine mammary tumor cells and endothelial cell tubulogenesis |
|
|
No disponible |
2024 |
| Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asper |
|
|
No disponible |
2024 |
| Caracterización de la toxicidad de venenos de serpiente sobre nauplios de Artemia salina y su utilidad para la evaluación de la potencia neutralizante de antivenenos ofídicos. |
|
|
No disponible |
2023 |
| Discovery and optimization of a broadly-neutralizing human antibody against long-chain α-neurotoxins from snakes |
|
|
No disponible |
2023 |
| Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2 |
|
|
2023 | |
| Virulent Brucella nosferati infecting Desmodus rotundus has emerging potential due to the broad foraging range of its bat host for humans and wild and domestic animals |
|
|
2023 | |
| Clostridium perfringens Phospholipase C, an Archetypal Bacterial Virulence Factor, induces the Formation of Extracellular Traps by Human Neutrophils |
|
|
2023 | |
| Lys49 myotoxins, secreted phospholipase A2-like proteins of viperid venoms: a comprehensive review |
|
|
No disponible |
2023 |
| Caracterización hidrogeológica del sistema kárstico Gabinarraca-Menonitas-La Higuera en la cuenca de la quebrada El Túnel, Venado de San Carlos, Alajuela, Costa Rica |
|
|
No disponible |
2023 |
| Quantification of snake venom proteomes by mass spectrometry-considerations and perspectives. |
|
|
No disponible |
2023 |
| SDS‑induced hexameric oligomerization of myotoxin‑II from Bothrops asper assessed by sedimentation velocity and nuclear magnetic resonance |
|
|
No disponible |
2023 |
| Skeletal muscle fiber hypercontraction induced by Bothrops asper myotoxic phospholipases A2 ex vivo does not involve a direct action on the contractile apparatus |
|
|
2023 | |
| Structural basis of the myotoxic inhibition of the Bothrops pirajai PrTX-I by the synthetic varespladib |
|
|
No disponible |
2023 |
| Proteomic profile of the venom of three dark-colored Tityus (Scorpiones: Buthidae) from the tropical rainforests of Costa Rica |
|
|
2023 | |
| Proteomic analysis of the mandibular glands from the Chinese crocodile lizard, Shinisaurus crocodilurus – another venomous lizard? |
|
|
No disponible |
2023 |
| Antibodies against a single fraction of Micrurus dumerilii venom neutralize the lethal effect of whole venom |
|
|
No disponible |
2023 |
| The recovery from the neuroparalysis caused by Micrurus nigrocinctus venom is accelerated by an agonist of the CXCR4 receptor |
|
|
No disponible |
2022 |
| Preliminary assessment of antivenom availability and management in the public health system of Costa Rica: An analysis based on a survey to pharmacists in public health facilities |
|
|
2022 | |
| Welfare assessment of horses ridden in the Costa Rica National Horse Parade |
|
|
No disponible |
2022 |
| Solving the microheterogeneity of Bothrops asper myotoxin-II by high-resolution mass spectrometry: insights into C-terminal region variability in Lys49-phospholipase A2 homologs |
|
|
No disponible |
2022 |
| First insights into the venom composition of two Ecuadorian coral snakes |
|
|
No disponible |
2022 |
| In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom. |
|
|
No disponible |
2022 |
| Proteomic and toxicological characterization of the venoms of the most enigmatic group of rattlesnakes: The long-tailed rattlesnakes |
|
|
No disponible |
2022 |
| Molecular architecture of the antiophidic protein DM64 and its binding specificity to myotoxin II from Bothrops asper venom |
|
|
No disponible |
2022 |
| In vivo treatment with varespladib, a phospholipase A2 inhibitor, prevents the peripheral neurotoxicity and systemic disorders induced by Micrurus corallinus (coralsnake) venom in rats |
|
|
No disponible |
2022 |
| Venomics of the scorpion Tityus ocelote (Scorpiones, Buthidae): Understanding venom evolution in the subgenus Archaeotityus |
|
|
2022 | |
| In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors |
|
|
2022 | |
| Half a century of research on Bothrops asper venom variation: biological and biomedical implications |
|
|
No disponible |
2022 |
| Partial efficacy of a Brazilian coralsnake antivenom and Varespladib to neutralize distinct toxic effects induced by a sublethal Micrurus dumerilii carinicauda envenoming in rats |
|
|
No disponible |
2022 |
| Proteomic and toxicological analysis of the venom of Micrurus yatesi and its neutralization by an antivenom |
|
|
2022 | |
| In vivo neutralization of Myotoxin II, a phospholipase A2 homolog from Bothrops asper venom, using peptides discovered via phage display technology |
|
|
No disponible |
2022 |
| Promoting co-existence between humans and venomous snakes through increasing the herpetological knowledge base |
|
|
No disponible |
2021 |
| Cytotoxicity of snake venom Lys49 PLA2-like myotoxin on rat cardiomyocytes ex vivo does not involve a direct action on the contractile apparatus |
|
|
2021 | |
| The earless monitor lizard Lanthanotus borneensis – a venomous animal? |
|
|
No disponible |
2021 |
| Heterologous hyperimmune polyclonal antibodies against SARS-COV-2: A broad coverage, affordable, and scalable potential immunotherapy for Covid-19 |
|
|
2021 | |
| Cardiac effect induced by Crotalus durissus cascavella venom: morphofunctional evidence and mechanism of action |
|
|
No disponible |
2021 |
| Mutual enlightenment: A toolbox of concepts and methods for integrating evolutionary and clinical toxinology via snake venomics and the contextual stance |
|
|
No disponible |
2021 |
| Importance of mevalonate pathway lipids on the growth and survival of primary and metastatic gastric carcinoma cells |
|
|
2021 | |
| Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms |
|
|
No disponible |
2021 |
| The synthetic Varespladib molecule is a multi-functional inhibitor for PLA2 and PLA2-like ophidic toxins |
|
|
No disponible |
2021 |
| Anexo 5: Guías de la OMS para la producción, control y regulación de inmunoglobulinas antiveneno de serpiente |
|
|
No disponible |
2021 |
| Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms |
|
|
2021 | |
| Effect on cell growth, viability and migration of geraniol and geraniol-containing essential oil from Lippia alba (Verbenaceae) on gastric carcinoma cells |
|
|
2021 | |
| High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern |
|
|
2021 | |
| What’s in a mass |
|
|
No disponible |
2021 |
| Localization of Myotoxin I and Myotoxin II from the venom of Bothrops asper in a murine model |
|
|
2021 | |
| Venomics of the poorly studied hognosed pitvipers Porthidium arcosae and Porthidium volcanicum |
|
|
|
2021 |
| Venomics of the Central American Lyre snake Trimorphodon quadruplex (Colubridae: Smith, 1941) from Costa Rica |
|
|
No disponible |
2020 |
| Preadipocytes are target cells for the actions of a representative gIIA phospholipase A2 which triggers proinflammatory pathways related to obesity |
|
|
No disponible |
2020 |
| Comparative biochemical characterization of Viperidae snake venoms from Perú reveals two compositional patterns of phospholipase A2 expression |
|
|
No disponible |
2020 |
| Manual de Métodos Inmunológicos |
|
|
No disponible |
2020 |
| Venom diversity in the neotropical genus Tityus: implications for antivenom design emerging from molecular and immunochemical analyses across endemic areas of scorpionism |
|
|
No disponible |
2020 |
| Tratamientos COVID-19 |
|
|
No disponible |
2020 |
| A lipidomic perspective of the action of group IIA secreted phospholipase A2 on human monocytes: lipid droplet biogenesis and activation of cytosolic phospholipase A2α |
|
|
No disponible |
2020 |
| Danger in the canopy: comparative proteomics and bioactivities of the venoms of the South American palm viper Bothrops bilineatus subspecies bilineatus and smaragdinus, and antivenomics of B. b. bilineatus (Rondônia) venom against the Brazilian pentabothropic antivenom |
|
|
No disponible |
2020 |
| Venomics of the Duvernoy's gland secretion of the false coral snake Rhinobothryum bovallii (Andersson, 1916) and assessment of venom lethality towards synapsid and diapsid animal models |
|
|
No disponible |
2020 |
| Potent virucidal activity against Flaviviridae of a group IIA phospholipase A2 isolated from the venom of Bothrops asper |
|
|
2020 | |
| Proteogenomic analysis of the Clostridium difficile exoproteome reveals a correlation between phylogenetic distribution and virulence potential |
|
|
2020 | |
| Genetic and toxinological divergence among populations of Tityus trivittatus Kraepelin, 1898 (Scorpiones: Buthidae) inhabiting Paraguay and Argentina |
|
|
No disponible |
2020 |
| An interactive database for the investigation of high-density peptide microarray guided interaction patterns and antivenom cross-reactivity |
|
|
No disponible |
2020 |
| Editorial: Novel immunotherapies against envenomings by snakes and other venomous animals |
|
|
No disponible |
2020 |
| Novel snakebite therapeutics must be tested in appropriate rescue models to robustly assess their preclinical efficacy |
|
|
No disponible |
2020 |
| 12-HETE is a regulator of PGE2 production via COX-2 expression induced by a snake venom group IIA phospholipase A2 in isolated peritoneal macrophages |
|
|
No disponible |
2020 |
| Oral administration of Costa Rican guava (Psidium friedrichsthalianum) juice induces changes in urinary excretion of energy-related compounds in Wistar rats determined by 1H NMR |
|
|
2020 | |
| Métodos de Investigación: destrezas básicas para el trabajo científico en las disciplinas biomédicas |
|
|
No disponible |
2020 |
| Snake venomics, experimental toxic activities and clinical characteristics of human envenomation by Bothrocophias myersi (Serpentes: Viperidae) from Colombia |
|
|
No disponible |
2020 |
| Mevalonate pathway as a novel target for the treatment of metastatic gastric cancer |
|
|
|
2020 |
| Venom variation in Bothrops asper lineages from north-western South America. |
|
|
No disponible |
2020 |
| Functional, proteomic and transcriptomic characterization of the venom from Micrurus browni browni: identification of the first lethal multimeric neurotoxin in coral snake venom |
|
|
No disponible |
2020 |
| Development of nanobodies against hemorrhagic and myotoxic components of Bothrops atrox snake venom |
|
|
No disponible |
2020 |
| Varespladib (LY315920) and methyl Varespladib (LY333013) abrogate or delay lethality induced by presynaptically-acting neurotoxic snake venoms |
|
|
No disponible |
2020 |
| Ontogenetic variation in the venom of Mexican Jumping Viper (Metlapilcoatlus nummifer) |
|
|
No disponible |
2020 |
| Immunological cross-recognition and neutralization studies of Micrurus mipartitus and Micrurus dumerilii venoms by two therapeutic equine antivenoms |
|
|
2020 | |
| Unity makes strength: exploring intra and interspecies toxin synergism between phospholipases A2 and cytotoxins |
|
|
No disponible |
2020 |
| New insights into the phylogeographic distribution of the 3FTx/PLA2 venom dichotomy across genus Micrurus in South America |
|
|
2019 | |
| Three-finger toxins from the venom of Micrurus tschudii (desert coral snake): isolation and characterization of tschuditoxin-I |
|
|
2019 | |
| Cloning, purification and characterization of nigrelysin, a novel actinoporin from the sea anemone Anthopleura nigrescens |
|
|
No disponible |
2019 |
| Biochemical characterization of the venom of Central American scorpion Didymocentrus krausi Francke, 1978 (Diplocentridae) and its toxic effects in vivo and in vitro |
|
|
2019 | |
| Enzymatic labelling of venom phospholipase A2 toxins |
|
|
No disponible |
2019 |
| Brazil nut intake increases circulating miR-454-3p and miR-584-5p in obese women |
|
|
No disponible |
2019 |
| Horse immunization with short-chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species |
|
|
2019 | |
| Novel three-finger toxins from Micrurus dumerilii and Micrurus mipartitus coral snake venoms: phylogenetic relationships and characterization of Clarkitoxin-I-Mdum |
|
|
2019 | |
| First look into the venom of Roatan Island´s critically endangered coral snake Micrurus ruatanus: proteomic characterization, toxicity, immunorecognition and neutralization by an antivenom |
|
|
2019 | |
| Isolation of two basic phospholipases A2 from Bothrops diporus snake venom: comparative characterization and synergism between Asp49 and Lys49 variants |
|
|
2019 | |
| Caracterización proteómica, funcional e inmunoneutralización del veneno de la serpiente Porthidium porrasi de Costa Rica |
|
|
No disponible |
2019 |
| Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) |
|
|
2019 | |
| Differences in plasmatic butyrylcholinesterases (BChE) values between Pacific and Caribbean populations of terciopelo (Bothrops asper) in Costa Rica |
|
|
2019 | |
| Proteomic profiling, functional characterization, and immunoneutralization of the venom of Porthidium porrasi, a pitviper endemic to Costa Rica |
|
|
2019 | |
| Reflexiones desde la academia. Universidad, ciencia y sociedad |
|
|
No disponible |
2019 |
| A secreted phospholipase A2 induces formation of smooth muscle foam cells which trans-differentiate to macrophage-like state |
|
|
No disponible |
2019 |
| Venom characterization of the bark scorpion Centruroides edwardsii (Gervais 1843): composition, biochemical activities and in vivo toxicity for potential prey |
|
|
2019 | |
| Neutralizing properties of Varespladib toward group I and II myotoxic phospholipases A2 |
|
|
2019 | |
| Venom characterization of the three species of Ophryacus and proteomic profiling of O. sphenophrys unveils Sphenotoxin, a novel Crotoxin-like heterodimeric β-neurotoxin |
|
|
No disponible |
2019 |
| Physical characteristics of nano-Hydroxyapatite Pickering-emulsions and their adjuvant activity on the antibody response towards the Bothros asper snake venom |
|
|
No disponible |
2019 |
| A myotoxic Lys49 phospholipase A2-homologue is the major component of the venom of Bothrops cotiara from Misiones, Argentina |
|
|
2018 | |
| Innovative immunization strategies for antivenom development |
|
|
No disponible |
2018 |
| Unresolved issues in the understanding of the pathogenesis of local tissue damage induced by snake venoms |
|
|
No disponible |
2018 |
| A novel pentameric phospholipase A2 myotoxin (PophPLA2) from the venom of the pit viper Porthidium ophryomegas |
|
|
2018 | |
| MipLAAO, a new L-amino acid oxidase from the redtail coral snake, Micrurus mipartitus |
|
|
2018 | |
| Effect of exposition to chlorpyrifos upon plasmatic cholinesterases, hematology and blood biochemistry values in Bothrops asper (Serpentes: Viperidae) |
|
|
2018 | |
| Biological and proteolytic variation in the venom of Crotalus scutulatus scutulatus from Mexico |
|
|
No disponible |
2018 |
| Pros and cons of different therapeutic antibody formats for recombinant antivenom development |
|
|
No disponible |
2018 |
| In vivo neutralization of the dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG monoclonal antibodies |
|
|
No disponible |
2018 |
| Myotoxin-neutralizing peptides |
|
|
No disponible |
2018 |
| Cell surface nucleolin interacts with and internalizes Bothrops asper Lys49 phospholipase A2 and mediates its toxic activity |
|
|
2018 | |
| Nociones de Inmunologia |
|
|
No disponible |
2018 |
| A snake venom secreted phospholipase A2 induces foam cell formation depending on the activation of factors involved in lipid homeostasis |
|
|
No disponible |
2018 |
| Cannibalism by large tadpoles of Rhinophrynus dorsalis (Anura: Rhinophrynidae) |
|
|
No disponible |
2018 |
| Depletion of complement enhances the clearance of Brucella abortus in mice |
|
|
2018 | |
| Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of Papuan Taipan (Oxyuranus scutellatus) venom |
|
|
No disponible |
2018 |
| Prolonged development of the middle ear in Rhinella horribilis |
|
|
No disponible |
2018 |
| Proteomic and toxinological characterization of the venom of the South African Ringhals cobra Hemachatus haemachatus |
|
|
2018 | |
| Intravascular hemolysis induced by phospholipases A2 from the venom of the Eastern coral snake, Micrurus fulvius: functional profile of hemolytic and non-hemolytic isoforms |
|
|
2018 | |
| Cross-recognition of a pit viper (Crotalinae) polyspecific antivenom explored through high-density peptide microarray epitope mapping |
|
|
No disponible |
2017 |
| Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A2 from the Central American coral snake, Micrurus nigrocinctus |
|
|
No disponible |
2017 |
| Strategies in 'snake venomics' aiming at an integrative view of compositional, functional, and immunological characteristics of venoms |
|
|
No disponible |
2017 |
| Brucellosis caused by the wood rat pathogen Brucella neotomae: two case reports |
|
|
No disponible |
2017 |
| High-density peptide microarray exploration of the antibody response in a rabbit immunized with a neurotoxic venom fraction |
|
|
No disponible |
2017 |
| Physicochemical characterization of Jicaro seeds (Crescentia alata H.B.K.): a novel protein-rich and oleaginous seed |
|
|
No disponible |
2017 |
| Proteomic analysis of venom variability and ontogeny across the arboreal palm-pitvipers (genus Bothriechis) |
|
|
No disponible |
2017 |
| Crystal structure of a phospholipase A2 from Bothrops asper venom: Insights into a new putative “myotoxic cluster” |
|
|
No disponible |
2017 |
| Detection of a synthetic sex steroid in the American crocodile (Crocodylus acutus): Evidence for a novel environmental androgen |
|
|
2017 | |
| Primary structures and partial toxicological characterization of two phospholipases A2 from Micrurus mipartitus and Micrurus dumerilii coral snake venoms |
|
|
2017 | |
| Comparison of biochemical and cytotoxic activities of extracts obtained from dorsal spines and caudal fin of adult and juvenile non-native Caribbean lionfish (Pterois volitans/miles) |
|
|
2017 | |
| Pitfalls to avoid when using phage display for snake toxins |
|
|
No disponible |
2017 |
| Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: State-of-the-art and challenges ahead |
|
|
No disponible |
2017 |
| Comparison of the adjuvant activity of emulsions with different physicochemical properties on the antibody response towards the venom of West African carpet viper (Echis ocellatus) |
|
|
2017 | |
| Proteoform-resolved quantitative venomics: looking through a crystal ball |
|
|
No disponible |
2017 |
| Screening for target toxins of the antiophidic protein DM64 through a gel-based interactomics approach |
|
|
No disponible |
2017 |
| Epidemiology of bovine brucellosis in Costa Rica: Lessons learned from failures in the control of the disease |
|
|
No disponible |
2017 |
| Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect |
|
|
No disponible |
2017 |
| Geographical variability of the venoms of four populations of Bothrops asper from Panama: Toxicological analysis and neutralization by a polyvalent antivenom |
|
|
No disponible |
2017 |
| Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleuca |
|
|
No disponible |
2017 |
| Venom of the Coral Snake Micrurus clarki: Proteomic Profile, Toxicity, Immunological Cross-Neutralization, and Characterization of a Three-Finger Toxin |
|
|
No disponible |
2016 |
| Characterization of a novel snake venom component: Kazal-type inhibitor-like protein from the arboreal pitviper Bothriechis schlegelii |
|
|
No disponible |
2016 |
| Neutralization of the neuromuscular inhibition of venom and taipoxin from the taipan (Oxyuranus scutellatus) by F(ab0)2 and whole IgG antivenoms |
|
|
No disponible |
2016 |
| The need for an integrated approach in confronting snakebite envenoming in Latin America: the relevance of endogenous scientific and technological research |
|
|
No disponible |
2016 |
| Muscle Tissue Damage Induced by the Venom of Bothrops asper: Identification of Early and Late Pathological Events through Proteomic Analysis |
|
|
No disponible |
2016 |
| Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics |
|
|
No disponible |
2016 |
| Hemorrhage Caused by Snake Venom Metalloproteinases: A Journey of Discovery and Understanding |
|
|
No disponible |
2016 |
| Mecanismo de açao dos venenos de cobras corais |
|
|
No disponible |
2016 |
| Lemnitoxin, the major component of Micrurus lemniscatus coral snake venom, is a myotoxic and pro-inflammatory phospholipase A2 |
|
|
No disponible |
2016 |
| A cryptic palm-pitviper species (Squamata: Viperidae: Bothriechis) from the Costa Rican highlands, with notes on the variation within B. nigroviridis |
|
|
No disponible |
2016 |
| Regional warming and the thermal regimes of American crocodile nests in the Tempisque Basin, Costa Rica |
|
|
No disponible |
2016 |
| Hydrology Affects Environmental and Spatial Structuring of Microalgal Metacommunities in Tropical Pacific Coast Wetlands |
|
|
2016 | |
| Bacterial Sphingomyelinases and Phospholipases as Virulence Factors |
|
|
2016 | |
| Venoms of Micrurus coral snakes: evolutionary trends in compositional patterns emerging from proteomic analyses |
|
|
2016 | |
| From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy |
|
|
No disponible |
2016 |
| High-throughput immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microarrays |
|
|
No disponible |
2016 |
| Brucella abortus Strain 2308 Wisconsin Genome: Importance of the Definition of Reference Strains |
|
|
No disponible |
2016 |
| Combined venomics, venom gland transcriptomics, bioactivities, and antivenomics of two Bothrops jararaca populations from geographic isolated regions within the Brazilian Atlantic rainforest |
|
|
No disponible |
2016 |
| Desarrollo de la herpetocultura en Costa Rica: Situación actual de herpetarios y manejo ex situ de reptiles y anfibios |
|
|
No disponible |
2016 |
| Pathogenesis of dermonecrosis induced by venom of the spitting cobra, Naja nigricollis: An experimental study in mice |
|
|
No disponible |
2016 |
| Understanding and confronting snakebite envenoming: The harvest of cooperation |
|
|
No disponible |
2016 |
| Integrative characterization of the venom of the coral snake Micrurus dumerilii (Elapidae) from Colombia: proteome, toxicity, and cross-neutralization by antivenom |
|
|
2016 | |
| Larval aggression is independent of food limitation in nurseries of a poison frog |
|
|
No disponible |
2016 |
| Novel catalytically-inactive PII metalloproteinases from a viperid snake venom with substitutions in the canonical zinc-binding motif |
|
|
2016 | |
| N-terminal peptide of myotoxin II from Bothrops asper venom enhances the activity of endothelin converting enzyme and neprilysin |
|
|
No disponible |
2016 |
| Development of a chicken-derived antivenom against the taipan snake (Oxyuranus scutellatus) venom and comparison with an equine antivenom |
|
|
No disponible |
2016 |
| Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: A biochemical and immunohistochemical study |
|
|
No disponible |
2016 |
| Metaloproteinasas dependientes de Zinc: Protagonistas centrales en la Fisiopatología de Envenenamientos por Serpientes de la familia Viperidae |
|
|
No disponible |
2016 |
| Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps). |
|
|
No disponible |
2016 |
| Methyltestosterone alters sex determination in the American alligator (Alligator mississippiensis) |
|
|
No disponible |
2016 |
| Venomic analysis of the poorly studied desert coral snake, Micrurus tschudii tschudii, supports the 3FTx/PLA2 dichotomy across Micrurus venoms |
|
|
No disponible |
2016 |
| Divergent functional profiles of acidic and basic phospholipases A2 in the venom of the snake Porthidium lansbergii lansbergii |
|
|
2016 | |
| Actividad letal de seis venenos de serpientes de importancia médica en el Ecuador |
|
|
No disponible |
2016 |
| Brucella abortus Induces the Premature Death of Human Neutrophils through the Action of Its Lipopolysaccharide |
|
|
No disponible |
2015 |
| Effect of geographical variation of Echis ocellatus, Naja nigricollis and Bitis arietans venoms on their neutralization by homologous and heterologous antivenoms |
|
|
No disponible |
2015 |
| A bright future for integrative venomics |
|
|
No disponible |
2015 |
| MmTX1 and MmTX2 from coral snake venom potently modulate GABAA receptor activity |
|
|
No disponible |
2015 |
| Brucella canis Is an Intracellular Pathogen That Induces a Lower Proinflammatory Response than Smooth Zoonotic Counterparts |
|
|
2015 | |
| Seasonal wetlands in the Pacific coast of Costa Rica and Nicaragua: environmental characterisation and conservation status |
|
|
2015 | |
| Group-II phospholipase A2 enzymes |
|
|
No disponible |
2015 |
| Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: identification of key toxin targets for antivenom development. |
|
|
No disponible |
2015 |
| Proteomic and functional analysis of the venom of Porthidium lansbergii lansbergii (Lansberg’s hognose viper) from the Atlantic Department of Colombia |
|
|
No disponible |
2015 |
| Purification of equine whole IgG snake antivenom by using an aqueous two phase system as a primary purification step |
|
|
2015 | |
| Antivenomics: a proteomics tool for studying the immunoreactivity of antivenoms |
|
|
2015 | |
| Improved biomass and protein production in solid-state cultures of an Aspergillus sojae strain harboring the Vitreoscilla hemoglobin |
|
|
No disponible |
2015 |
| Snake venomics of Micrurus alleni and Micrurus mosquitensis from the Caribbean region of Costa Rica reveals two divergent compositional patterns in New World elapids |
|
|
No disponible |
2015 |
| Assessing endotoxins in equine-derived snake antivenoms: Comparison of the USP pyrogen test and the Limulus Amoebocyte Lysate assay (LAL) |
|
|
2015 | |
| Phospholipases a2 from Viperidae snakes: Differences in membranotropic activity between enzymatically active toxin and its inactive isoforms |
|
|
No disponible |
2015 |
| Danger in the reef: Proteome, toxicity, and neutralization of the venom of the olive sea snake, Aipysurus laevis |
|
|
No disponible |
2015 |
| Tissue Localization and Extracellular Matrix Degradation by PI, PII and PIII Snake Venom Metalloproteinases: Clues on the Mechanisms of Venom-Induced Hemorrhage |
|
|
No disponible |
2015 |
| Índices bibliométricos y revistas de ‘corriente central’: implicaciones para el desarrollo de las ciencias naturales en Costa Rica |
|
|
No disponible |
2015 |
| Minipool Caprylic Acid Fractionation of Plasma Using Disposable Equipment: A Practical Method to Enhance Immunoglobulin Supply in Developing Countries |
|
|
No disponible |
2015 |
| Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria |
|
|
No disponible |
2015 |
| Lachesis stenophrys venom reduces the equine antibody response towards Bothrops asper venom used as co-immunogen in the production of polyspecific snake antivenom |
|
|
2015 | |
| A Call for Incorporating Social Research in the Global Struggle against Snakebite |
|
|
No disponible |
2015 |
| Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score |
|
|
No disponible |
2015 |
| Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins |
|
|
No disponible |
2015 |
| First crotoxin-like phospholipase A2 complex from a New World non-rattlesnake species: Nigroviriditoxin, from the arboreal Neotropical snake Bothriechis nigroviridis |
|
|
2015 | |
| Snakebites are associated with poverty, weather fluctuations, and El Niño |
|
|
No disponible |
2015 |
| The lethality test used for estimating the potency of antivenoms against Bothrops asper snake venom: Pathophysiological mechanisms, prophylactic analgesia, and a surrogate in vitro assay |
|
|
2015 | |
| Multiple paths to aquatic specialisation in four species of Central American Anolis lizards |
|
|
No disponible |
2015 |
| Extracts of Renealmia alpinia (Rottb.) MAAS Protect against Lethality and Systemic Hemorrhage Induced by Bothrops asper Venom: Insights from a Model with Extract Administration before Venom Injection |
|
|
No disponible |
2015 |
| Membrane-damaging and cytotoxic sphingomyelinases and phospholipases |
|
|
No disponible |
2015 |
| A constant area monolayer method to assess optimal lipid packing for lipolysis tested with several secreted phospholipases A2 |
|
|
2015 | |
| Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors |
|
|
No disponible |
2015 |
| Phospholipase A2 enhances the endothelial cell detachment effect of a snake venom metalloproteinase in the absence of catalysis |
|
|
2015 | |
| Venomics and antivenomics of Bothrops erythromelas from five geographic populations within the Caatinga ecoregion of northeastern Brazil |
|
|
No disponible |
2015 |
| Comparison of the adjuvant activity of aluminum hydroxide and calcium phosphate on the antibody response towards Bothrops asper snake venom |
|
|
No disponible |
2014 |
| Preclinical efficacy of Australian antivenoms against the venom of the small-eyed snake, Micropechis ikaheka, from Papua New Guinea: An antivenomics and neutralization study |
|
|
2014 | |
| Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays |
|
|
No disponible |
2014 |
| Snakebite Envenomingin Latin America and the Caribbean |
|
|
No disponible |
2014 |
| Venomous snakes of Costa Rica: biological and medical implications of their venom proteomic profiles analyzed through the strategy of snake venomics |
|
|
2014 | |
| Proteomic and toxicological profiling of the venom of Bothrocophias campbelli, a pitviper species from Ecuador and Colombia |
|
|
2014 | |
| Combined venom gland cDNA sequencing and venomics of the New Guinea small-eyed snake, Micropechis ikaheka |
|
|
2014 | |
| Current challenges for confronting the public health problem of snakebite envenoming in Central America |
|
|
No disponible |
2014 |
| Snake venomics of Bothrops punctatus, a semi-arboreal pitviper species from Antioquia, Colombia |
|
|
No disponible |
2014 |
| Two color morphs of the pelagic yellow-bellied sea snake, pelamis platura, from different locations of Costa Rica: snake venomics, toxicity, and neutralization by antivenom |
|
|
2014 | |
| Tissue Damage and Inflammation Induced by Snake Venoms |
|
|
No disponible |
2014 |
| Isolation and characterization of four medium-size disintegrins from the venoms of Central American viperid snakes of the genera Atropoides, Bothrops, Cerrophidion and Crotalus |
|
|
No disponible |
2014 |
| Understanding structural and functional aspects of PII snake venom metalloproteinases: Characterization of BlatH1, a hemorrhagic dimeric enzyme from the venom of Bothriechis lateralis |
|
|
No disponible |
2014 |
| Role of enzymatic activity inmuscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved? |
|
|
No disponible |
2014 |
| Anticomplementary Activity of Horse IgG and F(ab’)2 Antivenoms |
|
|
No disponible |
2014 |
| Intravascular hemolysis induced by the venom of the Eastern coral snake, Micrurus fulvius, in a mouse model: Identification of directly hemolytic phospholipases A2 |
|
|
No disponible |
2014 |
| A neutralizing recombinant single chain antibody, scFv, against BaP1, A P-I hemorrhagic metalloproteinase from Bothrops asper snake venom |
|
|
No disponible |
2014 |
| Toxicity of Bothrops sp snake venoms from Ecuador and preclinical assessment of the neutralizing efficacy of a polyspecific antivenom from Costa Rica |
|
|
No disponible |
2014 |
| An Asp49 Phospholipase A2 from Snake Venom Induces Cyclooxygenase-2 Expression and Prostaglandin E2 Production via Activation of NF-κB, p38MAPK, and PKC in Macrophages |
|
|
No disponible |
2014 |
| Utilidad de los péptidos sintéticos en estudios de estructura-función e identificación de epitopos en toxinas |
|
|
No disponible |
2014 |
| A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming |
|
|
No disponible |
2014 |
| The analgesics morphine and tramadol do not alter the acute toxicity induced by Bothrops asper snake venom in mice |
|
|
No disponible |
2014 |
| Omics Meets Biology: Application to the Design and Preclinical Assessment of Antivenoms |
|
|
No disponible |
2014 |
| Antivenomic Characterization of Two Antivenoms Against the Venom of the Taipan, Oxyuranus scutellatus, from Papua New Guinea and Australia |
|
|
No disponible |
2014 |
| Venomics of new world pit vipers: genus-wide comparisons of venom proteomes across Agkistrodon |
|
|
2014 | |
| Freeze-dried snake antivenoms formulated with sorbitol, sucrose or mannitol: Comparison of their stability in an accelerated test |
|
|
No disponible |
2014 |
| Industrial Production and Quality Control of Snake Antivenoms |
|
|
No disponible |
2014 |
| Proteomic and functional profiling of the venom of Bothrops ayerbei from Cauca, Colombia, reveals striking interspecific variation with Bothrops asper venom |
|
|
2014 | |
| A structure-based proposal for a comprehensive myotoxic mechanism of phospholipase A2-like proteins from viperid snake venoms |
|
|
No disponible |
2014 |
| Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead |
|
|
No disponible |
2014 |
| Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo |
|
|
2014 | |
| Evidence of maternal provisioning of alkaloid-based chemical defenses in the strawberry poison frog Oophaga pumilio |
|
|
No disponible |
2014 |
| Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation |
|
|
2014 | |
| Epidemiology of rapes in Costa Rica: Characterization of victims, perpetrators and circumstances surrounding forced intercourse |
|
|
No disponible |
2014 |
| Critical role of TLR2 and MyD88 for functional response of macrophages to a group IIA-Secreted phospholipase A2 from snake venom |
|
|
No disponible |
2014 |
| Why myotoxin-containing snake venoms possess powerful nucleotidases? |
|
|
No disponible |
2013 |
| Proteomic analysis of Bothrops pirajai snake venom and characterization of BpirMP, a new P-I metalloproteinase |
|
|
No disponible |
2013 |
| Amino acid sequence and biological characterization of BlatPLA2, a non-toxic acidic phospholipase A2 from the venom of the arboreal snake Bothriechis lateralis from Costa Rica |
|
|
2013 | |
| Muscle phospholipid hydrolysis by Bothrops asper Asp49 and Lys49 phospholipase A2 myotoxins – distinct mechanisms of action |
|
|
No disponible |
2013 |
| Assessing the preclinical efficacy of antivenoms: From the lethality neutralization assay to antivenomics |
|
|
No disponible |
2013 |
| A catalytically-inactive snake venom Lys49 phospholipase A2 homolog induces expression of cyclooxygenase-2 and production of prostaglandins through selected signaling pathways in macrophages |
|
|
No disponible |
2013 |
| Phospholipases A2: Unveiling the secrets of a functionally versatile group of snake venom toxins |
|
|
No disponible |
2013 |
| Preclinical assessment of a polyspecific antivenom against the venoms of Cerrophidion sasai, Porthidium nasutum and Porthidium ophryomegas: Insights from combined antivenomics and neutralization assays |
|
|
No disponible |
2013 |
| Polyspecific Antivenom Liquid |
|
|
No disponible |
2013 |
| Using Geographical Information Systems to Identify Populations in Need of Improved Accessibility to Antivenom Treatment for Snakebite Envenoming in Costa Rica |
|
|
No disponible |
2013 |
| Biochemical and biological characterization of two serine proteinases from Colombian Crotalus durissus cumanensis snake venom |
|
|
No disponible |
2013 |
| Guía de información: Serpientes de Costa Rica y prevención de mordeduras |
|
|
No disponible |
2013 |
| Systemic effects induced by the venom of the snake Bothrops caribbaeus in a murine model |
|
|
No disponible |
2013 |
| Suero antiofídico anti-coral |
|
|
No disponible |
2013 |
| New approaches & technologies of venomics to meet the challenge of human envenoming by snakebites in India |
|
|
No disponible |
2013 |
| Investigación colaborativa, generación de redes y coautoría de publicaciones: un estudio de caso del Instituto Clodomiro Picado |
|
|
No disponible |
2013 |
| The Need for Full Integration of Snakebite Envenoming within a Global Strategy to Combat the Neglected Tropical Diseases: The Way Forward |
|
|
No disponible |
2013 |
| Tratamiento hospitalario del envenenamiento por mordedura de serpiente |
|
|
No disponible |
2013 |
| Integrated “omics” profiling indicates that miRNAs are modulators of the ontogenetic venom composition shift in the Central American rattlesnake, Crotalus simus simus |
|
|
No disponible |
2013 |
| Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms |
|
|
No disponible |
2013 |
| Instituto Clodomiro Picado |
|
|
No disponible |
2013 |
| Suero antiofidico polivalente |
|
|
No disponible |
2013 |
| Generalidades de serpientes venenosas en Costa Rica |
|
|
No disponible |
2013 |
| Snake venomics of Lachesis muta rhombeata and genus-wide antivenomics assessment of the paraspecific immunoreactivity of two antivenoms evidence the high compositional and immunological conservation across Lachesis |
|
|
No disponible |
2013 |
| A Lys49 Phospholipase A2, Isolated from Bothrops asper Snake Venom, Induces Lipid Droplet Formation in Macrophages Which Depends on Distinct Signaling Pathways and the C-Terminal Region |
|
|
No disponible |
2013 |
| Algoritmo para el diagnóstico y tratamiento con antivenenos en pacientes mordidos por serpientes en Centroamérica |
|
|
No disponible |
2013 |
| Comparison of venom composition and biological activities of the subspecies Crotalus lepidus lepidus, Crotalus lepidus klauberi and Crotalus lepidus morulus from Mexico |
|
|
No disponible |
2013 |
| Role of the animal model on the pharmacokinetics of equine-derived antivenoms |
|
|
No disponible |
2013 |
| Intraspecies variation in the venom of the rattlesnake Crotalus simus from Mexico: Different expression of crotoxin results in highly variable toxicity in the venoms of three subspecies |
|
|
No disponible |
2013 |
| Homogenates of skeletal muscle injected with snake venom inhibit myogenic differentiation in cell culture |
|
|
No disponible |
2013 |
| Antivenom for snakebite envenoming in Sri Lanka: The need for geographically specific antivenom and improved efficacy |
|
|
No disponible |
2013 |
| Low pH formulation of whole IgG antivenom: Impact on quality, safety, neutralizing potency and viral inactivation |
|
|
No disponible |
2012 |
| Snake venomics of the pit vipers Porthidium nasutum, Porthidium ophryomegas, and Cerrophidion godmani from Costa Rica: Toxicological and taxonomical insights |
|
|
No disponible |
2012 |
| Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab0)2] antivenoms, in Bothrops asper bites in Colombia |
|
|
No disponible |
2012 |
| Inversión en ciencia, tecnología e innovación: proyectando a Costa Rica |
|
|
No disponible |
2012 |
| Comparative proteomic analysis of the venom of the taipan snake, Oxyuranus scutellatus, from Papua New Guinea and Australia: Role of neurotoxic and procoagulant effects in venom toxicity |
|
|
No disponible |
2012 |
| Snake venomics of crotalus tigris: the minimalist toxin arsenal of the deadliest neartic rattlesnake venom: evolutionary clues for generating a pan-specific antivenom against crotalid type II venoms |
|
|
No disponible |
2012 |
| Improving antivenom availability and accessibility: Science, technology, and beyond |
|
|
No disponible |
2012 |
| Efficacy of IgG and F(ab′)2 Antivenoms to Neutralize Snake Venom-induced Local Tissue Damage as Assessed by the Proteomic Analysis of Wound Exudate |
|
|
2012 | |
| La situación de los antivenenos liofilizados en América Latina: Aspectos tecnológicos y de salud pública |
|
|
No disponible |
2012 |
| Antiplasmodial effect of the venom of Crotalus durissus cumanensis, crotoxin complex and Crotoxin B |
|
|
No disponible |
2012 |
| Second generation snake antivenomics: Comparing immunoaffinity and immunodepletion protocols |
|
|
No disponible |
2012 |
| Snake venomics and antivenomics of Protobothrops mucrosquamatus and Viridovipera stejnegeri from Taiwan: Keys to understand the variable immune response in horses |
|
|
No disponible |
2012 |
| Investigación científica y tecnológica en el Instituto Clodomiro Picado: Una perspectiva bibliométrica de cuatro décadas (1970-2010) |
|
|
No disponible |
2012 |
| Implementación de un laboratorio de análisis proteómicos en el Instituto Clodomiro Picado (UCR): primeras experiencias en Costa Rica |
|
|
No disponible |
2012 |
| Purification of IgG and albumin from human plasma by aqueous two phase system fractionation |
|
|
No disponible |
2012 |
| Venenos de serpiente: de la investigación al tratamiento |
|
|
No disponible |
2012 |
| Identification of linear B-cell epitopes on myotoxin-II, a Lys49 phospholipase A2 homologue from Bothrops asper snake venom |
|
|
2012 | |
| Isolation and biochemical, functional and structural characterization of a novel L-amino acid oxidase from Lachesis muta snake venom |
|
|
No disponible |
2012 |
| Venom of Bothrops asper from Mexico and Costa Rica: Intraspecific variation and cross-neutralization by antivenoms |
|
|
2012 | |
| To beg or to freeze: multimodal sensory integration directs behavior in a tadpole |
|
|
No disponible |
2012 |
| Snake venom Lys49 myotoxins: from phospholipases A2 to non-enzymatic membrane disruptors |
|
|
2012 | |
| A Lys49-PLA2 myotoxin of Bothrops asper triggers a rapid death of macrophages that involves autocrine purinergic receptor signaling |
|
|
No disponible |
2012 |
| Identification of New Snake Venom Metalloproteinase Inhibitors Using Compound Screening and Rational Peptide Design |
|
|
No disponible |
2012 |
| Snake venomics and toxicological profiling of the arboreal pitviper Bothriechis supraciliaris from Costa Rica |
|
|
No disponible |
2012 |
| An acidic phospholipase A2 with antibacterial activity from Porthidium nasutum snake venom |
|
|
No disponible |
2012 |
| Envenomations by Bothrops and Crotalus Snakes Induce the Release of Mitochondrial Alarmins |
|
|
No disponible |
2012 |
| Resurrexit, sicut dixit, alleluia. Snake venomics from a 26-years old polyacrylamide focusing gel |
|
|
No disponible |
2012 |
| Mipartoxin-I, a novel three-finger toxin, is the major neurotoxic component in the venom of the redtail coral snake Micrurus mipartitus (Elapidae) |
|
|
2012 | |
| Venenos de serpientes de la familia Viperidae en América: Bioquímica y fisiopatología. |
|
|
No disponible |
2011 |
| Phospholipases A2 From Viperidae Snake Venoms: How do They Induce Skeletal Muscle Damage? |
|
|
No disponible |
2011 |
| Ending the drought: New strategies for improving the flow of affordable, effective antivenoms in Asia and Africa |
|
|
No disponible |
2011 |
| Proteomics of Wound Exudate in Snake Venom-Induced Pathology: Search for Biomarkers To Assess Tissue Damage and Therapeutic Success |
|
|
No disponible |
2011 |
| Role of collagens and perlecan in microvascular stability: exploring the mechanism of capillary vessel damage by snake venom metalloproteinases |
|
|
No disponible |
2011 |
| Desarrollo de las universidades públicas de Latinoamérica: una visión alternativa al modelo economicista de rentabilidad |
|
|
No disponible |
2011 |
| A phospholipase A2 from Bothrops asper snake venom activates neutrophils in culture: Expression of cyclooxygenase-2 and PGE2 biosynthesis |
|
|
No disponible |
2011 |
| Differences in escape behavior between a cryptic and an aposematic litter frog |
|
|
No disponible |
2011 |
| Venomic and antivenomic analyses of the Central American coral snake, Micrurus nigrocinctus (Elapidae) |
|
|
No disponible |
2011 |
| Método para la producción de formulaciones inyectables de productos proteicos hemoderivados y productos obtenidos utilizando dicho método |
|
|
2011 | |
| High resolution analysis of snake venom metalloproteinase (SVMP) peptide bond cleavage specificity using proteome based peptide libraries and mass spectrometry |
|
|
No disponible |
2011 |
| Snake population venomics and antivenomics of Bothrops atrox: Paedomorphism along its transamazonian dispersal and implications of geographic venom variability on snakebite management |
|
|
No disponible |
2011 |
| Membrane cholesterol modulates the cytolytic mechanism of myotoxin II, a Lys49 phospholipase A2 homologue from the venom of Bothrops asper |
|
|
No disponible |
2011 |
| Profiling the venom gland transcriptomes of Costa Rican snakes by 454 pyrosequencing |
|
|
No disponible |
2011 |
| Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: Implications for the production of polyspecific snake antivenoms |
|
|
2011 | |
| Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom |
|
|
2011 | |
| Proteomic and biological characterization of the venom of the redtail coral snake, Micrurus mipartitus (Elapidae), from Colombia and Costa Rica |
|
|
2011 | |
| Preclinical evaluation of caprylic-acid fractionated IgG antivenom for the treatment of taipan (Oxyuranus scutellatus) envneoming in Papua New Guinea |
|
|
No disponible |
2011 |
| Envenenamientos por mordeduras de serpientes en América Latina y el Caribe: Una visión integral de carácter regional |
|
|
No disponible |
2011 |
| Immune Response Towards Snake Venoms |
|
|
2011 | |
| Poor regenerative outcome after skeletal muscle necrosis induced by Bothrops asper venom: alterations in microvasculature and nerves |
|
|
2011 | |
| Antivenoms for Snakebite Envenomings |
|
|
No disponible |
2011 |
| Snake Venomics of African Spitting Cobras: Toxin Composition and Assessment of Congeneric Cross-Reactivity of the Pan-African EchiTAb-Plus-ICP Antivenom by Antivenomics and Neutralization Approaches |
|
|
2011 | |
| A group IIA-secreted phospholipase A2 from snake venom induces lipid body formation in macrophages: the roles of intracellular phospholipases A2 and distinct signaling pathways |
|
|
No disponible |
2011 |
| Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases |
|
|
2011 | |
| Antivenoms for the treatment of snakebite envenomings: The road ahead |
|
|
No disponible |
2011 |
| Neutralization of Bothrops mattogrossensis snake venom from Bolivia: Experimental evaluation of llama and donkey antivenoms produced by caprylic acid precipitation |
|
|
No disponible |
2010 |
| Synthetic peptides derived from the C-terminal region of Lys49 phospholipase A2 homologues from Viperidae snake venoms: biomimetic activities and potential applications |
|
|
No disponible |
2010 |
| Snake venomics of Bothriechis nigroviridis reveals extreme variability among palm pitviper venoms: different evolutionary solutions for the same trophic purpose |
|
|
No disponible |
2010 |
| Immunochemical and biological characterization of monoclonal antibodies against BaP1, a metalloproteinase from Bothrops asper snake venom |
|
|
No disponible |
2010 |
| Study of the design and analytical properties of the lethality neutralization assay used to estimate antivenom potency against Bothrops asper snake venom |
|
|
No disponible |
2010 |
| Antivenomics of Atropoides mexicanus and Atropoides picadoi snake venoms: Relationship to the neutralization of toxic and enzymatic activities |
|
|
No disponible |
2010 |
| Antivenomic Assessment of the Immunological Reactivity of EchiTAb-Plus-ICP, an Antivenom for the Treatment of Snakebite Envenoming in Sub-Saharan Africa |
|
|
No disponible |
2010 |
| The C-terminal region of a Lys49 myotoxin mediates Ca2þ influx in C2C12 myotubes |
|
|
No disponible |
2010 |
| Snake Venomics of the Central American Rattlesnake Crotalus simus and the South American Crotalus durissus Complex Points to Neurotoxicity as an Adaptive Paedomorphic Trend along Crotalus Dispersal in South America |
|
|
No disponible |
2010 |
| Backbone Flexibility Controls the Activity and Specificity of a Protein−Protein Interface: Specificity in Snake Venom Metalloproteases |
|
|
No disponible |
2010 |
| Bothrops snake myotoxins induce a large efflux of ATP and potassium with spreading of cell damage and pain |
|
|
No disponible |
2010 |
| Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms |
|
|
No disponible |
2010 |
| The Global Snake Bite Initiative: an antidote for snake bite |
|
|
No disponible |
2010 |
| Impact of Regional Variation in Bothrops asper Snake Venom on the Design of Antivenoms: Integrating Antivenomics and Neutralization Approaches |
|
|
No disponible |
2010 |
| Isolation of an acidic phospholipase A2 from the venom of the snake Bothrops asper of Costa Rica: Biochemical and toxicological characterization |
|
|
No disponible |
2010 |
| Snakebite envenoming from a global perspective: Towards an integrated approach |
|
|
No disponible |
2010 |
| Intravenous administration of equine-derived whole IgG antivenom does not induce early adverse reactions in non-envenomed horses and cows |
|
|
No disponible |
2010 |
| Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa |
|
|
No disponible |
2010 |
| Tissue pathology induced by snake venoms: How to understand a complex pattern of alterations from a systems biology perspective? |
|
|
No disponible |
2010 |
| Dr. Clodomiro Picado Twight (1887-1944) |
|
|
No disponible |
2010 |
| Acute physiopathological effects of honeybee (Apis mellifera) envenoming by subcutaneous route in a mouse model |
|
|
No disponible |
2010 |
| Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins |
|
|
No disponible |
2009 |
| Biochemistry and toxicology of toxins purified from the venom of the snake Bothrops asper |
|
|
No disponible |
2009 |
| Neutralization of Bothrops asper venom by antibodies, natural products, and synthetic drugs: contributions to understanding snakebite envenomings and their treatment |
|
|
No disponible |
2009 |
| Effects of Bothrops asper snake venom on the expression of cyclooxygenases and production of prostaglandins by peritoneal leukocytes in vivo, and by isolated neutrophils and macrophages in vitro |
|
|
No disponible |
2009 |
| Mortality by Hymenoptera stings in Costa Rica, 1985-2006 |
|
|
No disponible |
2009 |
| Hacia una mayor integración de las ciencias naturales y las ciencias sociales: análisis de un caso relacionado con un problema de salud pública |
|
|
No disponible |
2009 |
| Venom, venomics, antivenomics |
|
|
2009 | |
| Snake venomics and antivenomics of Bothrops atrox venoms from Colombia and the Amazon regions of Brazil, Perú and Ecuador suggest the occurrence of geographic variation of venom phenotype by a trend towards paedomorphism |
|
|
No disponible |
2009 |
| El envenenamiento por mordedura de serpiente en Centroamérica |
|
|
No disponible |
2009 |
| Bothrops asper: Beauty and peril in the Neotropics |
|
|
No disponible |
2009 |
| The Phospholipase A2 Homologues of Snake Venoms: Biological Activities and Their Possible Adaptive Roles |
|
|
No disponible |
2009 |
| Técnicas de Laboratorio en Inmunología Clínica |
|
|
No disponible |
2009 |
| Stability of equine IgG antivenoms obtained by caprylic acid precipitation: Towards a liquid formulation stable at tropical room temperature |
|
|
No disponible |
2009 |
| Experimental pathology of local tissue damage induced by Bothrops asper snake venom |
|
|
No disponible |
2009 |
| Snake venomics and antivenomics of Bothrops colombiensis, a medically important pitviper of the Bothrops atrox-asper complex endemic to Venezuela: Contributing to its taxonomy and snakebite management |
|
|
No disponible |
2009 |
| Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: Report of a workshop |
|
|
No disponible |
2009 |
| Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming |
|
|
No disponible |
2009 |
| High-Resolution Crystal Structure of the Snake Venom Metalloproteinase BaP1 Complexed with a Peptidomimetic: Insight into Inhibitor Binding |
|
|
No disponible |
2009 |
| Experimental pathophysiology of systemic alterations induced by Bothrops asper snake venom |
|
|
No disponible |
2009 |
| Calcium imaging of muscle cells treated with snake myotoxins reveals toxin synergism and presence of acceptors |
|
|
No disponible |
2009 |
| Systemic and local myotoxicity induced by snake venom group II phospholipases A2: Comparison between crotoxin, crotoxin B and a Lys49 PLA2 homologue |
|
|
No disponible |
2008 |
| Assessment of metalloproteinase inhibitors clodronate and doxycycline in the neutralization of hemorrhage and coagulopathy induced by Bothrops asper snake venom |
|
|
No disponible |
2008 |
| Ten simple rules for aspiring scientists in a low-income country |
|
|
No disponible |
2008 |
| Snake Venomics of Central American Pitvipers: Clues for Rationalizing the Distinct Envenomation Profiles of Atropoides nummifer and Atropoides picadoi |
|
|
No disponible |
2008 |
| Snake Venomics of the Lesser Antillean Pit Vipers Bothrops caribbaeus and Bothrops lanceolatus: Correlation with Toxicological Activities and Immunoreactivity of a Heterologous Antivenom |
|
|
No disponible |
2008 |
| Computational Biology in Costa Rica: the role of a small country in the global context of bioinformatics |
|
|
No disponible |
2008 |
| Snake Venomics and Antivenomics of the Arboreal Neotropical Pitvipers Bothriechis lateralis and Bothriechis schlegelii |
|
|
No disponible |
2008 |
| Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration |
|
|
2008 | |
| Skin Pathology Induced by Snake Venom Metalloproteinase: Acute Damage, Revascularization, and Re-epithelization in a Mouse Ear Model |
|
|
No disponible |
2008 |
| Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: comparison of high- and low-molecular weight fractions |
|
|
2008 | |
| Isolation and characterization of a serine proteinase with thrombin-like activity from the venom of the snake Bothrops asper |
|
|
No disponible |
2008 |
| Chemical composition of Schinus molle essential oil and its cytotoxic activity on tumour cell lines |
|
|
2008 | |
| Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via C-terminal loop region |
|
|
No disponible |
2008 |
| Effects of Bothrops asper snake venom on lymphatic vessels: insights into a hidden aspect of envenomation |
|
|
2008 | |
| Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action |
|
|
No disponible |
2008 |
| Secretory phospholipases A2 isolated from Bothrops asper and from Crotalus durissus terrificus snake venoms induce distinct mechanisms for biosynthesis of prostaglandins E2 and D2 and expression of cyclooxygenases |
|
|
No disponible |
2008 |
| Susceptibilidad de Trypanosoma cruzi a diferentes venenos de serpientes de Costa Rica |
|
|
No disponible |
2008 |
| Mortality due to snakebite envenomation in Costa Rica (1993–2006) |
|
|
No disponible |
2008 |
| Snake venomics of the South and Central American Bushmasters. Comparison of the toxin composition of Lachesis muta gathered from proteomic versus transcriptomic analysis |
|
|
No disponible |
2008 |
| Local and systemic pathophysiological alterations induced by a serine proteinase from the venom of the snake Bothrops jararacussu |
|
|
No disponible |
2007 |
| Role of cyclooxygenases in oedema-forming activity of bothropic venoms |
|
|
No disponible |
2007 |
| Antitumor effects of cationic synthetic peptides derived from Lys49 phospholipase A2 homologues of snake venoms |
|
|
No disponible |
2007 |
| Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations |
|
|
No disponible |
2007 |
| Isolation, characterization and molecular cloning of AnMIP, a new α-type phospholipase A2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae) |
|
|
2007 | |
| Increased Infectivity of Staphylococcus aureus in an Experimental Model of Snake Venom–Induced Tissue Damage |
|
|
No disponible |
2007 |
| Cytotoxicity of Lachesis muta muta snake (bushmaster) venom and its purified basic phospholipase A2 (LmTX-I) in cultured cells |
|
|
No disponible |
2007 |
| Structural and functional properties of BaTX, a new Lys49 phospholipase A2 homologue isolated from the venom of the snake Bothrops alternatus |
|
|
No disponible |
2007 |
| Cytotoxicity induced in myotubes by a Lys49 phospholipase A2 homologue from the venom of the snake Bothrops asper: Evidence of rapid plasma membrane damage and a dual role for extracellular calcium |
|
|
No disponible |
2007 |
| Trends in Snakebite Envenomation Therapy: Scientific, Technological and Public Health Considerations |
|
|
No disponible |
2007 |
| Strengthening antivenom production in Central and South American public laboratories: Report of a workshop |
|
|
No disponible |
2007 |
| The snake venom metalloproteinase BaP1 induces joint hypernociception through TNF-α and PGE2-dependent mechanisms |
|
|
No disponible |
2007 |
| Fungicidal activity of a phospholipase A2-derived synthetic peptide variant against Candida albicans |
|
|
No disponible |
2007 |
| Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity |
|
|
No disponible |
2006 |
| Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines |
|
|
No disponible |
2006 |
| Structure of myotoxin-II, a catalytically inactive Lys49 phospholipase A2 homologue from Atropoides nummifer venom |
|
|
No disponible |
2006 |
| Pharmacokinetics of whole IgG equine antivenom: comparison between normal and envenomed rabbits |
|
|
No disponible |
2006 |
| Inflammatory effects of BaP1 a metalloproteinase isolated from Bothrops asper snake venom: leukocyte recruitment and release of cytokines |
|
|
No disponible |
2006 |
| Effect of calcineurin inhibitors on myotoxic activity of crotoxin and Bothrops asper phospholipase A2 myotoxins in vivo and in vitro |
|
|
No disponible |
2006 |
| Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without β-propiolactone, in the treatment of Bothrops asper bites in Colombia |
|
|
No disponible |
2006 |
| Calcium plays a key role in the effects induced by a snake venom Lys49 phospholipase A2 homologue on a lymphoblastoid cell line |
|
|
No disponible |
2006 |
| Confronting the neglected problem of snake bite envneoming: the need for a global partnership |
|
|
No disponible |
2006 |
| Biological and structural characterization of crotoxin and new isoform of crotoxin B PLA2 (F6a) from Crotalus durissus collilineatus snake venom |
|
|
No disponible |
2006 |
| Role of nitric oxide in the local and systemic pathophysiological effects induced by Bothrops asper snake venom in mice |
|
|
No disponible |
2006 |
| Sexual dimorphism in the second-to-fourth digit length ratio in green anoles, Anolis carolinensis (Squamata: Polychrotidae), from the southeastern United States |
|
|
No disponible |
2006 |
| Blood flow is required for rapid endothelial cell damage induced by a snake venom hemorrhagic metalloproteinase |
|
|
No disponible |
2006 |
| Inhibition of Myotoxic Activity of Bothrops asper Myotoxin II by the Anti-trypanosomal Drug Suramin |
|
|
No disponible |
2005 |
| A cellular deficiency of gangliosides causes hypersensitivity to Clostridium perfringens phospholipase C |
|
|
No disponible |
2005 |
| Inflammation induced by Bothrops asper venom: release of proinflammatory cytokines and eicosanoids, and role of adhesion molecules in leukocyte infiltration |
|
|
No disponible |
2005 |
| Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 phospholipases A2 |
|
|
No disponible |
2005 |
| Characterization of events associated with apoptosis/anoikis induced by snake venom metalloproteinase BaP1 on human endothelial cells |
|
|
2005 | |
| Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols |
|
|
2005 | |
| A Lys49 phospholipase A2 homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line |
|
|
No disponible |
2005 |
| Role of TNF-α, IL-1β and IL-6 in the local tissue damage induced by Bothrops asper snake venom: an experimental assessment in mice |
|
|
2005 | |
| Bactericidal and anti-endotoxic properties of short cationic peptides derived from a snake venom Lys49 phospholipase A2 |
|
|
No disponible |
2005 |
| La investigación en la Universidad de Costa Rica: situación actual y perspectivas |
|
|
No disponible |
2005 |
| Differential susceptibility of C2C12 myoblasts and myotubes to group II phospholipase A2 myotoxins from crotalid snake venoms |
|
|
2005 | |
| Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs |
|
|
2005 | |
| Myotoxic and cytolytic activities of dimeric Lys49 phospholipase A2 homologues are reduced, but not abolished, by a pH-induced dissociation |
|
|
No disponible |
2005 |
| Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa |
|
|
No disponible |
2005 |
| Inhibitory effects of Piper umbellatum and Piper peltatum extracts towards myotoxic phospholipases A2 from Bothrops snake venoms: isolation of 4-nerolidylcatechol as active principle |
|
|
2005 | |
| Role of the snake venom toxin jararhagin in proinflammatory pathogenesis: In vitro and in vivo gene expression analysis of the effects of the toxin |
|
|
No disponible |
2005 |
| Inflammatory events induced by Lys-49 and Asp-49 phospholipases A2 isolated from Bothrops asper snake venom: role of catalytic activity |
|
|
No disponible |
2005 |
| Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage. |
|
|
No disponible |
2005 |
| Antimicrobial activity of myotoxic phospholipases A2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region |
|
|
2005 | |
| Medicinal plants with inhibitory properties against snake venoms |
|
|
No disponible |
2005 |
| Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2 |
|
|
No disponible |
2005 |
| Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment |
|
|
2005 | |
| Effects of neutrophil depletion in the local pathological alterations and muscle regeneration in mice injected with Bothrops jararaca snake venom |
|
|
2005 | |
| Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage |
|
|
No disponible |
2005 |
| Crystallization of the Lys49 PLA2 homologue, myotoxin II from the venom of Atropoides nummifer |
|
|
No disponible |
2004 |
| Feeding behavior and venom toxicity of coral snake Micrurus nigrocinctus (Serpentes: Elapidae) on its natural prey in captivity |
|
|
No disponible |
2004 |
| Snake venom phospholipase A2s (Asp49 and Lys49) induce mechanical allodynia upon peri-sciatic administration: involvement of spinal cord glia, proinflammatory cytokines and nitric oxide |
|
|
No disponible |
2004 |
| Effect of a recombinant Lys49 PLA2 myotoxin and Lys49 PLA2-derived synthetic peptides from Agkistrodon species on membrane permeability to water. |
|
|
No disponible |
2004 |
| Crystallization and preliminary X-ray diffraction analysis of suramin, a highly charged polysulfonated napthylurea, complexed with a myotoxic PLA2 from Bothrops asper venom |
|
|
No disponible |
2004 |
| Membrane independent activation of fibroblast proMMP-2 by snake venom: novel roles for venom proteinases |
|
|
No disponible |
2004 |
| Structural and functional characterization of myotoxin I, a Lys49 phospholipase A2 homologue from the venom of the snake Bothrops atrox |
|
|
2004 | |
| Bothrops asper metalloproteinase BaP1 is inhibited by alpha(2)-macroglobulin and mouse serum and does not induce systemic hemorrhage or coagulopathy |
|
|
No disponible |
2004 |
| Snake venom components enhance pain upon subcutaneous injection: an initial examination of spinal cord mediators |
|
|
No disponible |
2004 |
| Assessment of the viral safety of antivenoms fractionated from equine plasma |
|
|
No disponible |
2004 |
| Balances del Siglo XX: historia, microbiología, medicina y física |
|
|
No disponible |
2004 |
| Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants |
|
|
No disponible |
2003 |
| Efectos locales en el envenenamiento ofídico en América Latina |
|
|
No disponible |
2003 |
| Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue-damaging activities |
|
|
No disponible |
2003 |
| Intramuscular administration of antivenoms in experimental envenomation by Bothrops asper: comparison between Fab and IgG |
|
|
2003 | |
| Snake venom metalloproteinases: structure/function relationships studies using monoclonal antibodies |
|
|
No disponible |
2003 |
| Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom |
|
|
No disponible |
2003 |
| Characterization of 'basparin A,' a prothrombin-activating metalloproteinase, from the venom of the snake Bothrops asper that inhibits platelet aggregation and induces defibrination and thrombosis |
|
|
2003 | |
| Ontogenetic variability of Bothrops atrox and Bothrops asper snake venoms from Colombia |
|
|
2003 | |
| Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation. |
|
|
No disponible |
2003 |
| Comparative study of synthetic peptides corresponding to region 115-129 in Lys49 myotoxic phospholipases A2 from snake venoms |
|
|
No disponible |
2003 |
| Pulmonary hemorrhage induced by jararhagin, a metalloproteinase from Bothrops jararaca snake venom |
|
|
2003 | |
| Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A2 |
|
|
No disponible |
2003 |
| Polyspecific snake antivenom may help in antivenom crisis |
|
|
No disponible |
2003 |
| Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity |
|
|
No disponible |
2003 |
| Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes |
|
|
2003 | |
| An overview of Lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action |
|
|
No disponible |
2003 |
| A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa |
|
|
No disponible |
2003 |
| Comprendiendo los venenos de serpientes: 50 años de investigaciones en América Latina |
|
|
No disponible |
2002 |
| Hemostatic effects induced by Thalassophryne nattereri fish venom: a model of endothelium-mediated blood flow impairment. |
|
|
No disponible |
2002 |
| Functional analysis of DM64, an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum |
|
|
No disponible |
2002 |
| Structural characterization and phylogenetic relationships of myotoxin II from Atropoides (Bothrops) nummifer snake venom, a Lys49 phospholipase A2 homologue |
|
|
No disponible |
2002 |
| Effect of Preservatives on IgG Aggregation, Complement-activating Effect and Hypotensive Activity of Horse Polyvalent Antivenom Used in Snakebite Envenomation |
|
|
2002 | |
| Increments in cytokines and matrix metalloproteinases in skeletal muscle after injection of tissue-damaging toxins from the venom of the snake Bothrops asper |
|
|
No disponible |
2002 |
| Evaluation of antivenoms in the neutralization of hyperalgesia and edema induced by Bothrops jararaca and Bothrops asper snake venoms |
|
|
2002 | |
| Serum antibody response to polysaccharides in children with recurrent respiratory tract infections |
|
|
No disponible |
2001 |
| Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venom |
|
|
No disponible |
2001 |
| Venom of the crotaline snake Atropoides nummifer (jumping viper) from Guatemala and Honduras: comparative toxicological characterization, isolation of a myotoxic phospholipase A(2) homologue and neutralization by two antivenoms |
|
|
2001 | |
| The venom of Bothrops asper from Guatemala: toxic activities and neutralization by antivenoms |
|
|
2001 | |
| Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo |
|
|
No disponible |
2001 |
| Systemic cytokine response in children bitten by snakes in Costa Rica |
|
|
No disponible |
2001 |
| Skeletal muscle necrosis and regeneration after injection of Thalassophryne nattereri (niquim) fish venom in mice |
|
|
No disponible |
2001 |
| Pathological alterations induced by neuwiedase, a metalloproteinase isolated from Bothrops neuwiedi snake venom |
|
|
No disponible |
2001 |
| Effects of chemical modifications of crotoxin B, the phospholipase A2 subunit of crotoxin from Crotalus durissus terrificus snake venom, on its enzymatic and pharmacological activities |
|
|
No disponible |
2001 |
| Peligros de los falsos positivos en la determinación de gonadotropina coriónica |
|
|
No disponible |
2001 |
| Identification of the myotoxic site of the Lys49 phospholipase A2 from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities |
|
|
No disponible |
2001 |
| Modulation of the Susceptibility of Human Erythrocytes to Snake Venom Myotoxic Phospholipases A2: Role of Negatively Charged Phospholipids as Potential Membrane Binding Sites |
|
|
No disponible |
2001 |
| Immunochemical properties of the N-terminal helix of myotoxin II, a lysine-49 phospholipase A2 from Bothrops asper snake venom |
|
|
No disponible |
2001 |
| Comparison between IgG and F(ab′)2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions |
|
|
2001 | |
| Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom |
|
|
No disponible |
2001 |
| Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage |
|
|
2001 | |
| Horse IgG isotypes and cross-neutralization of two snake antivenoms produced in Brazil and Costa Rica |
|
|
2000 | |
| Bothrops asper snake venom and its metalloproteinase BaP–1 activate the complement system. Role in leucocyte recruitment |
|
|
2000 | |
| Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper |
|
|
2000 | |
| Snake venom metalloproteinases: Their role in the pathogenesis of local tissue damage |
|
|
2000 | |
| Structural and functional characterization of BnSP-7, a lysine-49 myotoxic phospholipase A2 homologue from Bothrops neuwiedi pauloensis venom |
|
|
No disponible |
2000 |
| Identification of residues critical for toxicity in Clostridium perfringens phospholipase C, the key toxin in gas gangrene |
|
|
2000 | |
| Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms |
|
|
No disponible |
2000 |
| Desarrollo científico en Costa Rica: un análisis bibliométrico a través del Science Citation Index durante el periodo 1980-1998 |
|
|
No disponible |
2000 |
| Purification and characterization of BaH4, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper |
|
|
2000 | |
| Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA |
|
|
2000 | |
| Myotoxic phospholipases A2 in Bothrops snake venoms: Effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu |
|
|
No disponible |
2000 |
| Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties |
|
|
2000 | |
| Isolation and characterization of myotoxin II from Atropoides (Bothrops) nummifer snake venom, a new Lys49 phospholipase A2 homologu |
|
|
No disponible |
2000 |
| Structural and functional characterization of myotoxin I, a Lys49 phospholipase A(2) homologue from Bothrops moojeni (Caissaca) snake venom |
|
|
No disponible |
2000 |
| Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom |
|
|
2000 | |
| Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica |
|
|
2000 | |
| Inhibition of the myotoxic activity of Bothrops aspermyotoxin II in mice by immunization with its synthetic 13-mer peptide 115-129 |
|
|
1999 | |
| Comparative study of the cytolytic activity of myotoxic phospholipases A2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro |
|
|
No disponible |
1999 |
| Crystal structure of myotoxin II, a monomeric Lys49-phospholipase A2 homologue isolated from the venom of Cerrophidion (Bothrops) godmani |
|
|
No disponible |
1999 |
| Universidad de Costa Rica: liderazgo en producción científica de nivel internacional, 1980-1998. |
|
|
No disponible |
1999 |
| Instituto Clodomiro Picado: Ciencia y Tecnología Endógenas en la Solución de un Problema de la Salud Pública en Centroamérica |
|
|
No disponible |
1999 |
| A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms |
|
|
1999 | |
| Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom |
|
|
1999 | |
| Venom Composition and Diet of the Cantil Agkistrodon bilineatus howardgloydi (Serpentes: Viperidae) |
|
|
No disponible |
1999 |
| Elapid venom toxins: multiple recruitments of ancient scaffolds |
|
|
No disponible |
1999 |
| Structure of a Lys49-Phospholipase A2 homologue isolated from the venom of Bothrops nummifer (jumping viper) |
|
|
No disponible |
1999 |
| Characterization of the local tissue damage induced by LHF-II, a metalloproteinase with weak hemorrhagic activity isolated from Lachesis muta muta snake venom |
|
|
1999 | |
| Bases moleculares del reconocimiento de antígenos |
|
|
No disponible |
1999 |
| Envenamiento por mordedura de serpiente en Costa Rica en 1996: Epidemiología y consideraciones clínicas |
|
|
No disponible |
1999 |
| Characterization of a basic phospholipase A2-homologue myotoxin isolated from the venom of the snake Bothrops neuwiedii (yarará chica) from Argentina |
|
|
No disponible |
1999 |
| Tyr→Trp-substituted peptide 115-129 of a Lys49 phospholipase A2 expresses enhanced membrane-damaging activities and reproduces its in vivo myotoxic effect |
|
|
No disponible |
1999 |
| Neutralization, by a monospecific Bothrops lanceolatus antivenom, of toxic activities induced by homologous and heterologous Bothı́rops snake venoms |
|
|
No disponible |
1999 |
| Immunochemical characterization and role in toxic activities of region 115-129 of myotoxin II, a Lys49 phospholipase A2 from Bothrops asper snake venom |
|
|
1998 | |
| Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo) |
|
|
1998 | |
| Inhibition by CaNa2EDTA of local tissue damage induced by Bothrops asper (terciopelo) venom: Application in horse immunization for antivenom production |
|
|
1998 | |
| Comparative study of the venoms of three subspecies of Lachesis muta (bushmaster) from Brazil, Colombia and Costa Rica |
|
|
No disponible |
1998 |
| Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom: synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region |
|
|
No disponible |
1998 |
| Blister formation and skin damage induced by BaP1, a haemorrhagic metalloproteinase from the venom of the snake Bothrops asper |
|
|
1998 | |
| Amino acid sequence of a myotoxic Lys49-phospholipase A2 homologue from the venom of Cerrophidion (Bothrops) godmani |
|
|
1998 | |
| Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom |
|
|
1998 | |
| Snakebite mortality in Costa Rica |
|
|
1997 | |
| Immunoglobulin G and F(ab')2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom |
|
|
No disponible |
1997 |
| Development of immunoassays for determination of circulating venom antigens during envenomations by coral snakes (Micrurus species) |
|
|
No disponible |
1997 |
| Neutralizing capacity of a new monovalent anti-Bothrops atrox antivenom: Comparison with two commercial antivenoms |
|
|
No disponible |
1997 |
| Inhibition of the hemorrhagic activity of Bothrops asper venom by a novel neutralizing mixture |
|
|
No disponible |
1997 |
| A comparison of in vitro methods for assessing the potency of therapeutic antisera against the venom of the coral snake Micrurus nigrocinctus |
|
|
No disponible |
1997 |
| Lys-49 phospholipases A2 as active enzymes for beta-arachidonoyl phospholipid bilayer membranes |
|
|
No disponible |
1997 |
| Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom |
|
|
No disponible |
1997 |
| Chemical modification of histidine and lysine residues of myotoxic phospholipases A2 isolated from Bothrops asper and Bothrops godmani snake venoms: effects on enzymatic and pharmacological properties |
|
|
No disponible |
1997 |
| Biochemical characterization and pharmacological properties of a phospholipase A2 myotoxin inhibitor from the plasma of the snake Bothrops asper |
|
|
1997 | |
| Inhibition of toxic activities of Bothrops asper venom and other crotalid snake venoms by a novel neutralizing mixture |
|
|
No disponible |
1997 |
| Isolation and characterization of a myotoxic phospholipase A2 from the venom of the arboreal snake Bothriechis (Bothrops) schlegelii from Costa Rica |
|
|
No disponible |
1997 |
| Evaluation of the neutralizing ability of antivenoms for the treatment of snake bite envenoming in Central America |
|
|
No disponible |
1996 |
| Similar effectiveness of Fab and F(ab')2 antivenoms in the neutralization of hemorrhagic activity of Vipera berus snake venom in mice |
|
|
No disponible |
1996 |
| Effect of adjuvants on the antibody response of mice to Bothrops asper (Terciopelo) snake venom |
|
|
No disponible |
1996 |
| Biochemical and biological characterization of Ecuadorian pitviper venoms (genera Bothriechis, Bothriopsis, Bothrops and Lachesis) |
|
|
No disponible |
1996 |
| Characterization of alpha-neurotoxin and phospholipase A2 activities from Micrurus venoms. Determination of the amino acid sequence and receptor-binding ability of the major alpha-neurotoxin from Micrurus nigrocinctus nigrocinctus |
|
|
No disponible |
1996 |
| Las citokinas, elementos centrales para la comprensión y manipulación terapéutica del sistema inmune (Parte II) |
|
|
No disponible |
1996 |
| A randomized double-blind clinical trial of two antivenoms in patients bitten by Bothrops atrox in Colombia |
|
|
No disponible |
1996 |
| Neutralization of myonecrosis, hemorrhage, and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice |
|
|
No disponible |
1996 |
| Antibody-mediated neutralization and binding-reversal studies on α-neurotoxins from micrurus nigrocinctus nigrocinctus (coral snake) venom |
|
|
No disponible |
1996 |
| Phospholipase A2 myotoxins from Bothrops snake venoms |
|
|
No disponible |
1995 |
| Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (Terciopelo) snake venom |
|
|
No disponible |
1995 |
| Evaluación de la capacidad de cuatro antivenenos comerciales para neutralizar el veneno de la serpiente Bothrops asper (terciopelo) de Costa Rica |
|
|
No disponible |
1995 |
| The ability of specific antivenom and low temperature to inhibit the myotoxicity and neuromuscular block induced by Micrurus nigrocinctus venom |
|
|
No disponible |
1995 |
| Skeletal Muscle Necrosis and Regeneration after Injection of BaH1, A Hemorrhagic Metalloproteinase Isolated from the Venom of the Snake Bothrops asper (Terciopelo) |
|
|
No disponible |
1995 |
| Phospholipase A2 myotoxins from Bothrops snake venoms [Artículo de revisión] |
|
|
No disponible |
1995 |
| In vitro activity of BaH1, the main hemorrhagic toxin of Bothrops asper snake venom on bovine endothelial cells |
|
|
No disponible |
1995 |
| Structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper venom |
|
|
No disponible |
1995 |
| Phospholipase A2 and inflammation |
|
|
No disponible |
1995 |
| Acute-phase reactions, including cytokines, in patients bitten by Bothrops and Crotalus snakes in Brazil |
|
|
No disponible |
1995 |
| Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice |
|
|
No disponible |
1995 |
| Autocatalytic acylation of phospholipase-like myotoxins |
|
|
No disponible |
1995 |
| Ability of six Latin American antivenoms to neutralize the venom of mapaná equis (Bothrops atrox) from Antioquia and Chocó (Colombia) |
|
|
No disponible |
1995 |
| Purification and characterization of myotoxin IV, a phospholipase A2 variant, from Bothrops asper snake venom |
|
|
No disponible |
1995 |
| Las citokinas, elementos centrales para la comprensión y manipulación terapéutica del sistema inmune (Parte 1) |
|
|
No disponible |
1995 |
| Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo) |
|
|
No disponible |
1995 |
| Immunological studies on BaH1 and BaPI, two hemorrhagic metalloproteinases from the venom of the snake Bothrops asper |
|
|
No disponible |
1995 |
| Immunochemical characterization of Micrurus nigrocinctus nigrocinctus venom with monoclonal and polyclonal antibodies |
|
|
No disponible |
1994 |
| Neutralizing interaction between heparins and myotoxin II, a Lys-49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling |
|
|
No disponible |
1994 |
| Cleavage of the NH2-Terminal Octapeptide of Bothrops asper Myotoxic Lysine-49 Phospholipase A2 Reduces Its Membrane-Destabilizing Effect |
|
|
No disponible |
1994 |
| Pathological changes induced by BaH1, a hemorrhagic proteinase isolated from Bothrops asper (Terciopelo) snake venom, on mouse capillary blood vessels |
|
|
No disponible |
1994 |
| A potent antihemorrhagin in the serum of the non-poisonous water snake Natrix tessellata: isolation, characterization and mechanism of neutralization |
|
|
No disponible |
1994 |
| Effect of various Viperidae and Crotalidae snake venoms on endothelial cells in vitro |
|
|
No disponible |
1994 |
| The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study |
|
|
No disponible |
1994 |
| Broad cytolytic specificity of myotoxin II, a lysine-49 phospholipase A2 of Bothrops asper snake venom |
|
|
No disponible |
1994 |
| Electrophoretic and immunochemical studies of Micrurus venoms |
|
|
No disponible |
1994 |
| Activity of hemorrhagic metalloproteinase BaH-1 and myotoxin II from Bothrops asper snake venom on capillary endothelial cells in vitro |
|
|
No disponible |
1994 |
| Neutralization of the cytolytic and myotoxic activities of phospholipases A2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family |
|
|
No disponible |
1994 |
| Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production |
|
|
No disponible |
1994 |
| Turbidity of hyperimmune equine antivenom: the role of phenol and serum lipoproteins |
|
|
No disponible |
1993 |
| p-Bromophenacyl bromide modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2, affects its pharmacological activities |
|
|
No disponible |
1993 |
| An MTT-based method for the in vivo quantification of myotoxic activity of snake venoms and its neutralization by antibodies |
|
|
No disponible |
1993 |
| Comparison of the immunogenicity and antigenic composition of ten Central American snake venoms |
|
|
No disponible |
1993 |
| Effects on cultured mammalian cells of myotoxin III, a phospholipase A2 isolated from Bothrops asper (terciopelo) venom |
|
|
No disponible |
1993 |
| Biological and biochemical activities of Vipera berus (European viper) venom |
|
|
No disponible |
1993 |
| Isolation and characterization of synergistic hemorrhagins from the venom of the snake Bothrops asper |
|
|
No disponible |
1993 |
| Crystallization and preliminary diffraction data of two myotoxins isolated from the venoms of Bothrops asper (Terciopelo) and Bothrops nummifer (jumping viper) |
|
|
No disponible |
1993 |
| Host response to Bothrops asper snake venom: analysis of edema formation, inflammatory cells, and cytokine release in a mouse model |
|
|
No disponible |
1993 |
| Effects of Bothrops asper (terciopelo) myotoxin III, a basic phospholipase A2, on liposomes and mouse gastrocnemius muscle |
|
|
No disponible |
1993 |
| Ultrastructural alterations in mouse capillary blood vessels after experimental injection of venom from the snake Bothrops asper (Terciopelo) |
|
|
No disponible |
1992 |
| Experimental myonecrosis induced by the venoms of South American Micrurus (coral snakes) |
|
|
No disponible |
1992 |
| Neutralization of myotoxic phospholipases A2 from the venom of the snake Bothrops asper by monoclonal antibodies |
|
|
No disponible |
1992 |
| Immunoenzymatic quantitation of antibodies to Bothrops asper myotoxins after polyvalent antivenom administration in mice. |
|
|
No disponible |
1992 |
| Individual expression patterns of myotoxin isoforms in the venom of the snake Bothrops Asper. |
|
|
No disponible |
1992 |
| Isolation and characterization of basic myotoxic phospholipases A2 from Bothrops godmani (Godman's pit viper) snake venom |
|
|
No disponible |
1992 |
| Calcium ion independent membrane leakage induced by phospholipase-like myotoxins |
|
|
No disponible |
1992 |
| Pathological and biochemical changes induced in mice after intramuscular injection of venom from newborn specimens of the snake Bothrops asper (Terciopelo) |
|
|
No disponible |
1992 |
| An electrophoretic study on phospholipase A2 isoenzymes in the venoms of Central American crotaline snakes |
|
|
No disponible |
1992 |
| Effect of Bothrops asper (Fer-De-Lance) snake venom on erythrocyte membrane. A comparative study |
|
|
No disponible |
1992 |
| A eficácia do antiveneno botrópico-crotálico na neutralização das principais atividades do veneno de Bothrops jararacussu |
|
|
No disponible |
1992 |
| Myotoxin II from Bothrops asper (Terciopelo) venom is a lysine-49 phospholipase A2 |
|
|
No disponible |
1991 |
| DNase activity in Costa Rican crotaline snake venoms: quantification of activity and identification of electrophoretic variants. |
|
|
No disponible |
1991 |
| Skeletal muscle degeneration and regeneration after injection of bothropstoxin-II, a phospholipase A2 isolated from the venom of the snake Bothrops jararacussu |
|
|
No disponible |
1991 |
| Neutralization of coral snake Micrurus nigrocinctus venom by a monovalent antivenom |
|
|
No disponible |
1991 |
| Quantitation by enzyme-immunoassay of antibodies against Bothrops myotoxins in four commercially-available antivenoms |
|
|
No disponible |
1991 |
| Degenerative and regenerative changes in murine skeletal muscle after injection of venom from the snake Bothrops asper: a histochemical and immunocytochemical study. |
|
|
No disponible |
1991 |
| The effect of myotoxins isolated from Bothrops snake venoms on multilamellar liposomes: relationship to phospholipase A2, anticoagulant and myotoxic activities |
|
|
No disponible |
1991 |
| Biochemical and pharmacological similarities between the venoms of newborn Crotalus durissus durissus and adult Crotalus durissus terrificus rattlesnakes |
|
|
No disponible |
1991 |
| The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper |
|
|
No disponible |
1990 |
| Standardization of assays for testing the neutralizing ability of antivenoms |
|
|
No disponible |
1990 |
| Equine antibodies to Bothrops asper myotoxin II: isolation from polyvalent antivenom and neutralizing ability. |
|
|
No disponible |
1990 |
| Effect of storage temperature on the stability of polyvalent antivenom produced in Costa Rica. |
|
|
No disponible |
1990 |
| South American snake venom proteins antigenically-related to Bothrops asper myotoxins. |
|
|
No disponible |
1990 |
| Ontogenetic changes in the venom of the snake Lachesis muta stenophrys (bushmaster) from Costa Rica |
|
|
No disponible |
1990 |
| Dissociation of enzymatic and toxic activities by the use of antibodies |
|
|
No disponible |
1990 |
| Isolation of a galactose-binding lectin from the venom of the snake Bothrops godmani (Godmann's pit viper). |
|
|
No disponible |
1990 |
| Isolation of basic myotoxins from Bothrops Moojeni and Bothrops Atrox snake venoms |
|
|
No disponible |
1990 |
| Histopathological and biochemical alterations induced by intramuscular injection of Bothrops asper (terciopelo) venom in mice |
|
|
No disponible |
1989 |
| A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo) |
|
|
No disponible |
1989 |
| El suero de neonatos de Clelia clelia (Serpentes: Colubridae) neutraliza la acción hemorrágica del veneno de Bothrops asper (Serpentes: Viperidae). |
|
|
No disponible |
1989 |
| Local tissue damage induced by Bothrops snake venoms - A review |
|
|
No disponible |
1989 |
| Desarrollo de la respuesta de anticuerpos anti-fosfolipasa A, en caballos inoculados con veneno para la producción de suero antiofídico polivalente en Costa Rica |
|
|
No disponible |
1989 |
| Myonecrosis induced in mice by a basic myotoxin isolated from the venom of the snake Bothrops nummifer (jumping viper) from Costa Rica |
|
|
No disponible |
1989 |
| Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom |
|
|
No disponible |
1989 |
| Efecto del suero antiofídico sobre la actividad hemolítica del complemento humano (in vitro) y de conejo (in vitro e in vivo). |
|
|
No disponible |
1989 |
| A new method for the detection of phospholipase A2 variants: identification of isozymes in the venoms of newborn and adult Bothrops asper (terciopelo) snakes |
|
|
No disponible |
1988 |
| Body distribution of Bothrops asper (terciopelo) snake venom myotoxin and its relationship to pathological changes |
|
|
No disponible |
1988 |
| An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica |
|
|
No disponible |
1988 |
| Production and partial characterization of monoclonal antibodies to Bothrops asper (terciopelo) myotoxin |
|
|
No disponible |
1988 |
| Karyotypes of five species of coral snakes (Micrurus) |
|
|
No disponible |
1988 |
| El suero antiofídico polivalente producido en Costa Rica: Estabilidad y capacidad neutralizante |
|
|
No disponible |
1988 |
| Ability of a polyvalent antivenom to neutralize the venom of Lachesis muta melanocephala, a new Costa Rican subspecies of the bushmaster |
|
|
No disponible |
1987 |
| Antibody neutralization of a myotoxin from the venom of Bothrops asper (terciopelo) |
|
|
No disponible |
1987 |
| Skeletal muscle necrosis induced by a phospholipase A2 isolated from the venom of the coral snake Micrurus nigrocinctus nigrocinctus. |
|
|
No disponible |
1987 |
| Neutralización de las actividades tóxicas y enzimáticas de cuatro venenos de serpientes de Guatemala y Honduras por el antiveneno polivalente producido en Costa Rica |
|
|
No disponible |
1987 |
| Detection of proteins antigenically-related to Bothrops asper myotoxin in crotaline snake venoms |
|
|
No disponible |
1987 |
| Effects of a myotoxic phospholipase A2 isolated from Bothrops asper venom on skeletal muscle sarcoplasmic reticulum |
|
|
No disponible |
1987 |
| Immunohistochemical demonstration of the binding of bothrops asper myotoxin to skeletal muscle sarcolemma |
|
|
No disponible |
1987 |
| Pathogenesis of myonecrosis induced by coral snake (Micrurus nigrocinctus) venom in mice |
|
|
No disponible |
1986 |
| Isolation and partial characterization of a myotoxin from the venom of the snake Bothrops nummifer |
|
|
No disponible |
1986 |
| Determinación cuantitativa de la actividad lítica del complemento sérico (CH50) en adultos costarricenses |
|
|
No disponible |
1986 |
| Algunas reflexiones sobre Clodomiro Picado Twight y su contribución al desarrollo de las ciencias médicas y naturales de Costa Rica |
|
|
No disponible |
1986 |
| Cálculo de la actividad hemolítica del complemento sérico (CH50) mediante un programa en "BASIC": Comparación con el método gráfico manual. |
|
|
No disponible |
1986 |
| Pharmacological activities of a toxic phospholipase A isolated from the venom of the snake Bothrops asper |
|
|
No disponible |
1986 |
| Inflammatory infiltrate in skeletal muscle injected with Bothrops asper venom |
|
|
No disponible |
1986 |
| Comparative study of the edema-forming activity of Costa Rican snake venoms and its neutralization by a polyvalent antivenom |
|
|
No disponible |
1986 |
| Edema-forming activity of bushmaster (Lachesis muta stenophrys) and Central American rattlesnake (Crotalus durissus durissus) venoms and neutralization by a polyvalent antivenom |
|
|
No disponible |
1985 |
| Porcentaje y cifra absoluta de linfocitos T en sangre periférica por el método de rosetas E: estudio de cuarenta adultos sanos |
|
|
No disponible |
1985 |
| Producción de placas de inmunodifusión radial para la cuantificación de IgG humana |
|
|
No disponible |
1985 |
| Cambios en el patrón electroforético del veneno de cascabela muda (Lachesis muta stenophrys) durante el almacenamiento bajo diferentes condiciones |
|
|
No disponible |
1985 |
| Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom |
|
|
No disponible |
1985 |
| Niveles de inmunoglobulinas séricas (IgG, IgA e IgM) en adultos jóvenes sanos, por el método de inmunodifusión radial |
|
|
No disponible |
1985 |
| Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom |
|
|
1985 | |
| Mecanismo de acción de miotoxinas aisladas de venenos de serpientes |
|
|
No disponible |
1984 |
| Skeletal muscle regeneration after myonecrosis induced by crude venom and a myotoxin from the snake Bothrops asper (Fer-de-Lance). |
|
|
No disponible |
1984 |
| Estudios cariológicos de cinco especies de serpientes costarricenses de la familia colubridae |
|
|
No disponible |
1984 |
| Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper. |
|
|
No disponible |
1984 |
| Isolation of a myotoxin from Bothrops asper venom: Partial characterization and action on skeletal muscle |
|
|
No disponible |
1984 |
| Estudio comparativo de los venenos de serpiente Cascabel (Crotalus durissus durissus) de ejemplares adultos y recien nacidos |
|
|
No disponible |
1983 |
| Local effects induced by coral snake venoms: Evidence of myonecrosis after experimental inoculations of venoms from five species |
|
|
No disponible |
1983 |
| La actividad proteolítica de los venenos de serpientes de Costa Rica sobre la caseína |
|
|
No disponible |
1983 |
| Patogénesis y neutralización de los efectos locales inducidos por el veneno de la serpiente "terciopelo" (Bothrops asper). |
|
|
No disponible |
1982 |
| Quantitation of myonecrosis induced by myotoxin a from prairie rattlesnake (Crotalus viridis viridis) venom |
|
|
No disponible |
1982 |
| Estudio de la capacidad ofiófaga y la resistencia de la zopilota (Clelia clelia, Colubridae) de Costa Rica a los venenos de serpiente |
|
|
No disponible |
1982 |
| Neutralization of local effects of the terciopelo (Bothrops asper) venom by blood serum of the colubrid snake Clelia clelia |
|
|
No disponible |
1982 |
| Polimorfismo cromosómico intraespecífico en la serpiente de coral Micrurus nigrocinctus (Ophidia: Elapidae) |
|
|
No disponible |
1981 |
| Anemias hemolíticas por autoinmunidad y por mecanismos inmunes inducidos por medicamentos |
|
|
No disponible |
1981 |
| El problema de los efectos hemorrágico y mionecrótico por mordeduras de serpiente en el continente Americano |
|
|
No disponible |
1980 |
| Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en ratón blanco |
|
|
No disponible |
1980 |
| Karyotype of the yellow-bellied sea snake, Pelamis platurus |
|
|
No disponible |
1980 |
| Efectos proteolitico, hemorragico y mionecrotico de los venenos de serpientes costarricenses de los generos Bothrops, Crotalus y Lachesis |
|
|
No disponible |
1980 |
| Estudio comparativo de venenos de ejemplares recien nacidos y adultos de Bothrops asper |
|
|
No disponible |
1980 |
| Cariotipos de diez especies de serpientes costarricenses de la familia Viperidae |
|
|
No disponible |
1979 |
| Cariotipos de las principales serpientes coral (Elapidae: Micrurus) de Costa Rica |
|
|
No disponible |
1979 |
| CÓDIGO PROYECTO | NOMBRE PROYECTO | INFORME | FECHA DE ENTREGA |
|
ENLACE | |
|---|---|---|---|---|---|---|
| No hay datos disponibles | ||||||